Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 2AMOXICILLIN
02 1DABIGATRAN ETEXILATE MESYLATE
03 1PONSTEL
04 1REBETOL
05 1SELEGILINE HYDROCHLORIDE
06 3TRIAMTERENE AND HYDROCHLOROTHIAZIDE
07 1ZIPRASIDONE HYDROCHLORIDE
01 115034
02 120903
03 162881
04 162884
05 173191
06 174821
07 175352
08 177562
09 1208040
10 1208358
01 10No
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : AMOXICILLIN
Dosage Form : CAPSULE; ORAL
Application Number : 62884
Country : US
Patented : No
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : AMOXICILLIN
Dosage Form : CAPSULE; ORAL
Application Number : 62881
Country : US
Patented : No
Drug : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE; ORAL
Application Number : 208040
Country : US
Patented : No
Drug : PONSTEL
Dosage Form : CAPSULE; ORAL
Application Number : 15034
Country : US
Patented : No
HYDROCHLOROTHIAZIDE; TRIAMTERENE
Drug : TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Dosage Form : CAPSULE; ORAL
Application Number : 208358
Country : US
Patented : No
HYDROCHLOROTHIAZIDE; TRIAMTERENE
Drug : TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Dosage Form : CAPSULE; ORAL
Application Number : 73191
Country : US
Patented : No
Drug : REBETOL
Dosage Form : CAPSULE; ORAL
Application Number : 20903
Country : US
Patented : No
Drug : SELEGILINE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 75352
Country : US
Patented : No
Drug : ZIPRASIDONE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77562
Country : US
Patented : No
HYDROCHLOROTHIAZIDE; TRIAMTERENE
Drug : TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Dosage Form : CAPSULE; ORAL
Application Number : 74821
Country : US
Patented : No
